NASDAQ:AVBP | Balance Sheet | ArriVent BioPharma, Inc.

Complete source-backed balance-sheet history.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical Balance Sheet

DateCash and equivalentsCurrent securitiesReceivablesInventoryOther current assetsCurrent assetsProperty, plant and equipmentOther noncurrent assetsTotal assetsAccounts payableCurrent liabilitiesLong-term debtOther noncurrent liabilitiesTotal liabilitiesShareholder equity
2026-06-30$154.68M$218.44M$394.17M$134,000.00$394.72M$2.22M$27.84M$27.88M$366.84M
2026-03-31$62.1M$264.28M$348.7M$156,000.00$349.3M$8.73M$25M$25.32M$323.98M
2025-12-31$45.54M$267.28M$332.9M$190,000.00$333.17M$5.93M$25.95M$25.95M$307.22M
2025-09-30$112.67M$187.59M$321.22M$180,000.00$326.56M$5.93M$21.56M$21.56M$305M
2025-06-30$112.77M$122.92M$250.15M$479,000.00$269.51M$4.06M$19.64M$19.64M$249.87M
2025-03-31$49.87M$126.21M$185.79M$176,000.00$215.5M$4.36M$12.95M$12.95M$202.54M
2024-12-31$74.29M$144.57M$226.98M$126,000.00$274.94M$3.78M$17.27M$17.29M$257.65M
2024-09-30$282.86M$292.4M$126,000.00$292.71M$4.65M$15.16M$15.22M$277.49M
2024-06-30$298.67M$308.51M$125,000.00$308.86M$3.81M$12.1M$12.2M$296.66M
2024-03-31$317.39M$327.48M$108,000.00$327.84M$4.1M$9.98M$10.12M$317.72M
2023-12-31$150.39M$159.97M$107,000.00$163.1M$4.53M$11.62M$11.8M-$153.19M
2023-09-30$141.36M-$132.6M
2023-06-30$157.83M-$118.46M
2023-03-31$191.46M-$97.09M
2022-12-31$163.37M-$85.11M